Last Price
8.39
Today's Change
-0.012 (0.14%)
Day's Change
8.32 - 8.74
Trading Volume
24,762
Market Cap
207 Million
Shares Outstanding
24 Million
Avg Volume
49,711
Avg Price (50 Days)
7.78
Avg Price (200 Days)
8.37
PE Ratio
-6.27
EPS
-1.34
Earnings Announcement
06-Mar-2025
Previous Close
8.41
Open
8.63
Day's Range
8.32 - 8.7493
Year Range
7.11 - 11.42
Trading Volume
24,788
1 Day Change
-0.14%
5 Day Change
2.29%
1 Month Change
14.26%
3 Month Change
-3.25%
6 Month Change
12.73%
Ytd Change
5.64%
1 Year Change
-20.99%
3 Year Change
-24.68%
5 Year Change
7.53%
10 Year Change
-17.54%
Max Change
-17.54%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.